期刊文献+

转基因动物在肥厚型心肌病研究中的应用

Application of transgenic animal in hypertrophic cardiomyopathy
下载PDF
导出
摘要 Hypertrophic cardiomyopathy is an autosomal-dominant disease.Disease-causing mutations have been found in genes encoding structural components of the thick and thin filament systems of cardiac myocyte;it has therefore been named as a disease of sarcomere.Many approaches have been used to characterize the pathogenesis of the desease.Transgenic animal models have been created to gain further insight into the pathogenesis of this disease.Most of these models has been made in mice;however,recently a transgenic rabbit model has been created.In addition,there are several natural-occurring forms of HCM in animals.The discovery of responsible genes and the elucidation of the molecular mechanisms of pathogenesis through the use of animal models promise improved and early diagnosis and the potential for mechanism-based therapeutics. SUMMARY Hypertrophic have been found in genes e cardiomyopathy is an autosomal-dominant disease. Disease-causing mutations ncoding structural components of the thick and thin filament systems of cardiac myoeyte ; it has therefore been named as a disease of sareomere. Many approaches have been used to characterize the pathogenesis of the desease. Transgenic animal models have been created to gain further insight into the pathogenesis of this disease. Most of these models has been made in mice ; however, recently a transgenic rabbit model has been created. In addition,there are several natural-occurring forms of HCM in animals. The discovery of responsible genes and the elucidation of the molecular mechanisms of pathogenesis through the use of animal models promise improved and early diagnosis and the potential for mechanism-based therapeutics.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2007年第6期666-669,共4页 Journal of Peking University:Health Sciences
基金 国家自然科学基金(30540038)资助~~
关键词 心肌病 肥厚性 动物 基因修饰 突变 Cardiomyopathy, hypertrophic Animals, genetically modified Mutation
  • 相关文献

参考文献20

  • 1Maron BJ, McKenna WJ, Danielsen GK, et al. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines [ J ]. J Am Coll Cardiol, 2003, 42:1687 - 1713.
  • 2Maron BJ, Shirani J, Poliae LC, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles[J]. JAMA, 1996, 276:199-204.
  • 3Marian AJ, Robert R. The molecular genetic basis for hypertrophic cardiomyo pathy [J] . J Mol cell Cardiol, 2001, 33:655 -670.
  • 4Gavin D, Lan N. Progression of left ventricular hypertrophy and the angiotensin converting enzyme gene polymorphism in hypertrophic cardiomyopathy[J]. Cardiology, 2004, 96 : 157 - 163.
  • 5Laforet P,Richard P, Said MA, et al. A new mutation in PRKAG gene causing hypertrophic cardiomyopathy with conduction system disease and muscularglycogensis[ J]. Neummuscul Diserd, 2006, 16 : 178 - 182.
  • 6Hughes SE, Mckenna WI. New insights into the pathology of inherited cardiomyopathy[ J ]. Heart,2005,91 : 257 -264.
  • 7Jaenisch R, Mintz BS. Virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA[ J]. Proc Nail Acad Sci USA, 1974, 71:1250 -1254.
  • 8胡卫江.基因工程动物[M].郝光荣.试验动物学.第2版.上海:第二军医大学出版社,2002:220-222.
  • 9Maass A, Leinwand LA. Animal models of hypertrophic cardiomyopathy[J]. Curr Opin Cardiol, 2000, 15:189 - 196.
  • 10Geisterfer-Lowrance A.AT, Christe ME, Conner DA, et al. A mouse model of familial hy-pertrophic cardiomyopathy [ J ]. Science, 1996, 272:731 -734.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部